GB0004415D0 - Proteins and their use for diagnosis and treatment of schizophrenia - Google Patents

Proteins and their use for diagnosis and treatment of schizophrenia

Info

Publication number
GB0004415D0
GB0004415D0 GB0004415A GB0004415A GB0004415D0 GB 0004415 D0 GB0004415 D0 GB 0004415D0 GB 0004415 A GB0004415 A GB 0004415A GB 0004415 A GB0004415 A GB 0004415A GB 0004415 D0 GB0004415 D0 GB 0004415D0
Authority
GB
United Kingdom
Prior art keywords
schizophrenia
diagnosis
proteins
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0004415A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0004415A priority Critical patent/GB0004415D0/en
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of GB0004415D0 publication Critical patent/GB0004415D0/en
Priority to AU2001237543A priority patent/AU2001237543A1/en
Priority to PCT/GB2001/000783 priority patent/WO2001063293A2/en
Priority to AU2001233954A priority patent/AU2001233954A1/en
Priority to PCT/GB2001/000792 priority patent/WO2001062785A2/en
Priority to EP01905991A priority patent/EP1259818A2/en
Priority to EP01909957A priority patent/EP1259607A2/en
Priority to JP2001562208A priority patent/JP2003528300A/en
Priority to AU35891/01A priority patent/AU3589101A/en
Priority to PCT/IB2001/000259 priority patent/WO2001063295A2/en
Priority to EP01908032A priority patent/EP1224471B1/en
Priority to AT01908032T priority patent/ATE255229T1/en
Priority to DE60101305T priority patent/DE60101305D1/en
Priority to US10/051,618 priority patent/US20030190615A1/en
Ceased legal-status Critical Current

Links

GB0004415A 2000-02-24 2000-02-24 Proteins and their use for diagnosis and treatment of schizophrenia Ceased GB0004415D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB0004415A GB0004415D0 (en) 2000-02-24 2000-02-24 Proteins and their use for diagnosis and treatment of schizophrenia
AU2001237543A AU2001237543A1 (en) 2000-02-24 2001-02-23 Proteins, genes and their use for diagnosis and treatment of schizophrenia
PCT/GB2001/000783 WO2001063293A2 (en) 2000-02-24 2001-02-23 Diagnosis and treatment of schizophrenia
AU2001233954A AU2001233954A1 (en) 2000-02-24 2001-02-23 Proteins, genes and their use for diagnosis and treatment of schizophrenia
PCT/GB2001/000792 WO2001062785A2 (en) 2000-02-24 2001-02-23 Protein and gene and their use for diagnosis and treatment of schizophrenia
EP01905991A EP1259818A2 (en) 2000-02-24 2001-02-23 Diagnosis and treatment of schizophrenia
EP01909957A EP1259607A2 (en) 2000-02-24 2001-02-23 Protein and gene and their use for diagnosis and treatment of schizophrenia
JP2001562208A JP2003528300A (en) 2000-02-24 2001-02-26 DPI-6, putative therapeutic targets and biomarkers in neuropsychiatric and neurological disorders
DE60101305T DE60101305D1 (en) 2000-02-24 2001-02-26 DPI-6, A THERAPEUTIC BIOMARKER IN NEUROLOGICAL DISEASES
AU35891/01A AU3589101A (en) 2000-02-24 2001-02-26 Dpi-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders
PCT/IB2001/000259 WO2001063295A2 (en) 2000-02-24 2001-02-26 Dpi-6, a therapeutic biomarker in neurological disorders
EP01908032A EP1224471B1 (en) 2000-02-24 2001-02-26 Dpi-6, a therapeutic biomarker in neurological disorders
AT01908032T ATE255229T1 (en) 2000-02-24 2001-02-26 DPI-6, A THERAPEUTIC BIOMARKER IN NEUROLOGICAL DISEASES
US10/051,618 US20030190615A1 (en) 2000-02-24 2002-06-10 DPI-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0004415A GB0004415D0 (en) 2000-02-24 2000-02-24 Proteins and their use for diagnosis and treatment of schizophrenia

Publications (1)

Publication Number Publication Date
GB0004415D0 true GB0004415D0 (en) 2000-04-12

Family

ID=9886346

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0004415A Ceased GB0004415D0 (en) 2000-02-24 2000-02-24 Proteins and their use for diagnosis and treatment of schizophrenia

Country Status (1)

Country Link
GB (1) GB0004415D0 (en)

Similar Documents

Publication Publication Date Title
DE60020367D1 (en) AIRFUL CLOTHING FOR INCREASING THE COMFORT OF THE HUMAN BODY
IL157577A0 (en) Disposable underpants and method of providing the same
IL153824A0 (en) Method and kit for diagnosis of diseases
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
SG100740A1 (en) Disposable pants of trunks-type
GB0015745D0 (en) Treatment of bone diseases
AU2002367535A8 (en) Diagnosis and treatment of vascular disease
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
HK1043348A1 (en) Brush-writing instruments for health and therapy
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
IL161854A0 (en) Heterocyclic derivatives of glycinamide and their medical use
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003268295A8 (en) "diagnosis and treatment of infertility"
GB0023915D0 (en) Treatment of neuroinflammatory disease
EP1351699A4 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2001237543A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
GB2360453B (en) Treatment of skin conditions
IL162509A0 (en) Use of deoxypeganine for treating clinical depression
EP1322778A4 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
GB0004415D0 (en) Proteins and their use for diagnosis and treatment of schizophrenia
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
EP1409734A4 (en) Diagnosis and treatment of cancer
GB0008326D0 (en) Diagnosis and treatment of autism and related disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)